- Home
- NBIX vs PNW Comparison
NBIX vs PNW Comparison
Compare NBIX & PNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- PNW
- Stock Information
- Founded
- NBIX 1992
- PNW 1985
- Country
- NBIX United States
- PNW United States
- Employees
- NBIX N/A
- PNW N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- PNW Electric Utilities: Central
- Sector
- NBIX Health Care
- PNW Utilities
- Exchange
- NBIX Nasdaq
- PNW Nasdaq
- Market Cap
- NBIX 11.0B
- PNW 10.3B
- IPO Year
- NBIX 1996
- PNW N/A
- Fundamental
- Price
- NBIX $87.58
- PNW $88.88
- Analyst Decision
- NBIX Buy
- PNW Buy
- Analyst Count
- NBIX 21
- PNW 10
- Target Price
- NBIX $164.80
- PNW $93.75
- AVG Volume (30 Days)
- NBIX 1.3M
- PNW 1.2M
- Earning Date
- NBIX 04-30-2025
- PNW 05-01-2025
- Dividend Yield
- NBIX N/A
- PNW 4.00%
- EPS Growth
- NBIX 33.20
- PNW 18.82
- EPS
- NBIX 3.29
- PNW 5.24
- Revenue
- NBIX $2,355,300,000.00
- PNW $5,124,915,000.00
- Revenue This Year
- NBIX $15.48
- PNW $1.07
- Revenue Next Year
- NBIX $16.18
- PNW $5.81
- P/E Ratio
- NBIX $26.38
- PNW $17.10
- Revenue Growth
- NBIX 24.81
- PNW 9.13
- 52 Week Low
- NBIX $86.58
- PNW $70.72
- 52 Week High
- NBIX $157.98
- PNW $96.50
- Technical
- Relative Strength Index (RSI)
- NBIX 20.83
- PNW 36.52
- Support Level
- NBIX $113.05
- PNW $87.44
- Resistance Level
- NBIX $112.74
- PNW $96.50
- Average True Range (ATR)
- NBIX 3.20
- PNW 2.03
- MACD
- NBIX -1.46
- PNW -0.66
- Stochastic Oscillator
- NBIX 4.59
- PNW 15.89
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About PNW Pinnacle West Capital Corporation
Pinnacle West is a holding company whose principal subsidiary is Arizona Public Service, a vertically integrated electric utility that serves 1.4 million customers across a 35,000-square-mile territory in central Arizona, including Phoenix. APS owns or leases more than 6 gigawatts of power generation capacity, including a 29% ownership stake in the largest nuclear plant in the US, Palo Verde. Half of the electricity that APS supplies to customers comes from clean energy sources, including nuclear.